JAMA Network Home
Sign In
Editorial

Is There Still Room for Monotherapy in EGFR-Mutated Non–Small Cell Lung Cancer?

JAMA 10.1001/jama.2026.13325

August 10, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Maxime Borgeaud, MD, Department of Oncology, Geneva University Hospital, 4 Gabrielle-Perret-Gentil Street, 1205 Geneva, Switzerland (maxime.borgeaud@hug.ch).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.13325?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081026

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks